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Humanized miceRheumatoid arthritis (RA) is an autoimmune disease with unknown etiology though both genetic
and environmental factors have been suggested to be involved in its pathogenesis. While infections
and other environmental factors (e.g. smoking) have been studied extensively and show some asso-
ciation, a direct link between all the factors has been difﬁcult to prove. With the recent advances in
technology, it has become possible to sequence the commensals that are residing in our gut. The gut
microbiome may provide the missing link to this puzzle and help solve the mystery of many leaky
gut syndromes. The gut commensals are involved in maintaining host immune homeostasis and
function suggesting that they might be critical in altering the immune system, which leads to auto-
immune diseases like RA. Mouse models support the role of the gut microbiota in predisposition to
RA. If that is true, the power of gut-derived commensal can be harnessed to our beneﬁt by generat-
ing a biomarker proﬁle along with genetic factors to deﬁne individuals at risk and by altering the
gut microbial composition using various means.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.Rheumatoid arthritis (RA) is an autoimmune disease of
unknown etiology. It has a world-wide distribution affecting
approximately 1% of the population. The main causal factor for
RA is the immunologic dysregulation that leads to inﬂammation.
RA is characterized by the presence of autoreactive T and B cells
directed to synovial proteins, which leads to inﬂammation of the
synovial joints followed by joint damage. Over the decades, signif-
icant clinical and scientiﬁc work has helped us to understand its
pathology, yet the factor(s) that cause RA are still unknown. How-
ever from the vast literature, it is clear that its pathogenesis
requires interaction between genetic and environmental factors
[1]. Among genetic factors, several gene variants have been identi-
ﬁed. Genome-wide association studies and other studies have
revealed that the genes located in the Major Histocompatibility
complex (MHC) provide the strongest association with susceptibil-
ity to develop RA. The presence of certain HLA-class II alleles that
share the sequence at position 60–74 in the third hypervariable
region 3 (HVR3) with the DRB1*0401 gene, ‘‘shared epitope’’, were
shown to occur more often in RA patients as compared to controls
[2]. However, not all individuals carrying those genes develop RA.
Recent studies have implicated variants of some genes that could
contribute to severity of disease although with much lower impact
than HLA genes [3]. Low concordance rate of RA in monozygotictwins indicates involvement of other factors in addition to genetic
factors. Interaction between genetic and environmental factors
may explain some of the risk for susceptibility to RA. Among the
environmental factors, smoking and infections have been associ-
ated with development and pathogenesis of RA. Smoking has been
studied extensively and has been shown to be associated with
seropositive disease in genetically predisposed individuals [1].
An infectious etiology of RA has been proposed for decades
although conclusive evidence is lacking. Infectious agents like
Proteus mirabilis, speciﬁc Escherichia coli, Mycoplasma fermentans,
Klebsiella pneumonia and Porphyromonas gingivalis have been
linked to inﬂammatory arthritis in many ethnic populations
[4–8]. However, a causal link between infections and onset of RA
has been difﬁcult to prove. The concept called ‘‘molecular mim-
icry’’ was proposed to explain the role of infectious agents in RA.
According to this concept, cross-reactivity between epitopes of
the microbial origin with a self-protein that share similarities with
infectious agents can cause dysregulation in immune response,
crossing a threshold that ensue autoimmunity. Indeed, presence
of antibodies to certain bacteria has been described in RA patients
[9]. For example, sequences ESRRAL found P. mirabilis share simi-
larities with sequences at amino acid position 67–74 of the shared
epitope [6]. Antibodies to P. mirabilis and cell membrane proteins
of mycoplasma have been observed in RA patients. Similarly
rheumatoid factor positivity has been associated with the presence
of E. coli and Klebsiella in the gut [5]. As RA is characterized by
the presence of autoantibodies, these studies suggest that the
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onset of disease and environmental factors may contribute as a
second hit in genetically predisposed individuals. While the known
RA-associated HLA genes and environment may still not explain
causation in all individuals, a recent study with humanized mice
showing how non-associated HLA molecules can contribute to sus-
ceptibility to arthritis supports the interaction between genetic
and environmental factors for susceptibility to disease. Besides
bacterial infections, certain viruses like Epstein Barr virus (EBV),
Cytomegalovirus (CMV) and Parvovirus B19 have also been impli-
cated in RA [10–12].Fig. 1. Rheumatoid arthritis is a multifactorial disease that involves both genetic
and environmental factors. Among genetic factors, HLA alleles provide the strongest
risk while among environmental factors, smoking and infections are involved. A
role of hormones and changes in immune system during aging are also associated
with pathogenesis of rheumatoid arthritis. All the factors that inﬂuence RA also
impact the gut microbial composition. Gut microbiome provides a link between all
the factors that inﬂuence RA. An individual may harbor a core gut microbiome and
certain species may contract or expand depending on the exposure to various
environmental factors thus inﬂuencing the immune system locally in the gut as
well as adaptive immune system.1. Microbiome and immune response
Despite enormous efforts, ﬁnding a single pathogen that could
predict susceptibility to RA has failed. During the last decade our
understanding of the interaction between microbes and host has
evolved. The major human organs that are exposed to environment
are the skin and gut. The human gut harbors vast numbers of
bacteria that exceed the number of cells in one’s body. There is
conclusive evidence that the gut microﬂora and its components
are essential for maintaining homeostasis in the gut as well as in
the systemic immune system [13–15]. Besides maintaining a bal-
anced mucosal immune system, these gut bacteria aid in digestion
of certain foods and harvesting energy.
Innate immunity is our ﬁrst line of defense against pathogens.
Toll like receptors (TLRs) present on the surface of cells of innate
immunity recognize conserved pathogen associated molecular pat-
terns (PAMPs), activating NFkB pathways leading to activation of
T cells and cytokine production [16]. TLR4 activation has been
shown to determine disease severity in animal models of RA [17]
and release of proinﬂammatory cytokines by synovial tissue [18].
Lipopolysaccharides (LPS) are important components of the outer
membrane of all gram negative bacteria. TLR4 is a natural ligand
for LPS and as soon as it binds LPS, all cells expressing TLR4 and
pattern recognition receptors (PRRs) get activated, resulting in
secretion of inﬂammatory cytokines and other defensive mecha-
nisms. TLR4 stimulation activates MyD88-dependent pathways
that drive inﬂammatory gene expression leading to induction of
proinﬂammatory cytokines of the adaptive immune system [19].
Now there is a growing realization that intestinal bacteria, via
their components or metabolites, may also be involved in adaptive
immune response and, thus, play a substantial role in allergies and
autoimmune diseases [20].2. Microbiome and rheumatoid arthritis
Predisposition to RA is associated with the presence of certain
HLA genes and environmental factors like smoking and infections
[21,22]. Age and sex of an individual can inﬂuence development
of RA, as the mean age of patients is around 50 years and it occurs
twice as often in women. All the factors that can impact the devel-
opment of RA including the host genotype, smoking, infections,
hormones and aging also inﬂuence the gut microbiome (Fig. 1).
Genotype and sex are strong determinants of the gut microbiota
[23,24] though dynamic changes occur in the gut microbial compo-
sition with aging, [25]. In humans, age-related changes in the gut
microbial composition are associated with enrichment of patho-
bionts [26]. These changes may lead to loss or gain of metabolic
function in the gut causing imbalance. Smoking is known to alter
immune response locally in the lungs in RA patients [1], but has
also been shown to impact the gut microbiome [25]. Smoking ces-
sation changes the gut microbial composition by increasing diver-
sity [27], suggesting low diversity in the gut of smokers with RA
may cause a dysbiosis. Thus the gut may be a link by which thegenetic and environmental factors associated with arthritis cause
an abnormality in immune response.
Infection as an etiologic factor for RA is supported by the suc-
cess of antibiotic treatment of some RA patients. While many
pathogens have been linked to pathogenesis of RA, P. gingivalis, a
commensal present in the oral cavity, has been the major focus
of recent investigations as it provides a direct link between envi-
ronmental factors and RA [28]. It is a gram negative bacterium that
is present in the gingival crevice of periodontitis patients as well as
in healthy individuals, though in lower numbers. Smoking has
been strongly correlated to P. gingivalis infection. Epidemiological
studies linking periodontal disease and RA were initially suggested
on the basis of the presence of antibodies to P. gingivalis. RA is
characterized by the presence of antibodies to citrullinated
proteins. A high prevalence of periodontitis has been observed in
– new-onset RA patients even in the absence of smoking [29].
Among the known commensals, P. gingivalis is the only bacterium
that has been shown to express the endogenous peptidyl arginine
deiminase (PAD) enzyme required for citrullination of proteins.
Thus P. gingivalis could be involved in the autoimmune process
by generating citrullinated proteins of self as well as human anti-
gen and the immune response to them [30]. Individuals with a
genetic predisposition or other susceptibility factors and P. gingiva-
lis infection are more likely to develop cellular and humoral
responses to the citrullinated antigens. Patients with RA have been
shown to be positive for antibodies to citrullinated a-enolase
peptide 1 (CEP-1) that cross reacts with bacterial enolase. A corre-
lation between the presence of anti-citrullinated antibodies (ACPA)
to CEP-1 and positivity for shared epitope further suggests that
citrullinated CEP-1 may have a role in pathogenesis of RA [31].
Animal studies have shown that infection with P. gingivalis can
exacerbate the disease severity of arthritis [32]. Bacterial PAD
enzymes can citrullinate human proteins that may lead to a break
in tolerance resulting in an autoimmune response to CEP and other
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ﬁrmed by the presence of DNA of P. gingivalis from synovial ﬂuid
of RA patients [33]
3. Gut microbiome in pathogenic response
The notion that gut bacteria are involved in adaptive immunity
is not novel. As early as 1908, the Nobel laureate Metchkinov sug-
gested that aging-associated deﬁciencies came from certain bacte-
rial toxins from the gut and lactic acid producing bacteria can
reverse those changes [34]. That was the ﬁrst inkling into the role
of gut commensals in adaptive immunity and its involvement in
changes in the systemic immune system. Ever since his discovery,
scientists have been trying to determine how gut bacteria affects
the overall health of humans. The signiﬁcance of the intestinal bac-
teria in rheumatology was realized when presence of certain bac-
teria were associated with the development of reactive arthritis.
Studies showing the presence of certain commensal bacterial
DNA in synovial ﬂuids of patients [1,35,36] supported the concept
that in genetically susceptible individuals exposure to degraded
products of the gut bacteria locally in synovium may cause inﬂam-
mation. Indeed, infections like Yersinia, Shigella, Salmonella and
Campylobacter can trigger arthritis, especially in individuals carry-
ing HLA-B27.
This led to the hypothesis that intestinal bacterial products may
be present in circulation and arthritogenic bacteria may cause
inﬂammation in synovial tissues. Evidence for this comes from
the presence of bacterial cell wall products in the joints of patients
and differences observed between intestinal bacterial composition
in RA patients and healthy individuals [37,38]. Also, there is evi-
dence suggesting that host MHC genes may affect the microbiolog-
ical milieu of the gut [39,40]. Increased levels of antibodies
directed against antigens of certain gut bacteria in RA patients sug-
gests a pathogenic relationship between these bacteria and RA
[41]. Animal studies showing susceptibility to develop arthritis
when exposed to bacterial cell walls support this contention
[42,43].
4. Genetics of gut microbiota
There is limited information on the inﬂuence of host genotype
on the gut microbial composition. Initial studies with twins
showed that the composition of fecal and nasal ﬂora was much
more similar in identical twins compared to non-identical twins.
Studies carried out with congenic strains of mice showed a strong
effect of host genotype on the gut ﬂora [44]. These studies did not
show that susceptibility to a disease might be associated with spe-
ciﬁc gut microbes or dysbiosis. The advent of humanized mice
helped resolve this issue. Recent studies with humanized mice
expressing RA-associated and non-associated HLA genes show a
difference in gut microbial composition between the 2 strains, sug-
gesting that MHC genes may be involved directly or indirectly in
determining the intestinal microbial composition [23]. However
the mechanism by which MHC molecules can impact gut microbial
colonization was unclear. One way MHC molecules impact the gut
microbiota could be by binding the proteins on the bacterial cell
surface and inﬂuencing adherence to the epithelial cells and bacte-
rial colonization.
More recently, studies by Mazmanian and coworkers have
shown that polysaccharides produced by Bacteroides fragilis may
form a complex with MHC II, which is internalized and then pre-
sented, leading to activation of CD4 T cells [45]. Introduction of
B. fragilis in germ-free mice has been shown to correct a defect in
the CD4 T cell population observed in germ-free mice. These stud-
ies suggested that microbes are required for the development ofthe immune system and one can speculate this to be one way for
the host genotype to inﬂuence microbial colonization.5. Hygiene hypothesis
Composition of the gut microbiota is inﬂuenced by many factors
including diet, geographical location and environmental factors
like smoking and infectious agents. The hygiene hypothesis put
forth in the 1980s was formulated to explain the role of microbes
in shaping immune tolerance [46]. According to the hygiene
hypothesis, personal hygiene and smaller family size in the devel-
oped world has led to low burden of pathogenic microbes and an
increase in autoimmune diseases. This is supported by increased
incidence of various autoimmune conditions like type I diabetes,
inﬂammatory bowel disease and RA in developed countries. This
hypothesis has been modiﬁed to assume that the modern life style
has altered the gut microbial diversity causing dysbiosis [47,48].
The low microbial load can cause ﬁxed microﬂora or change the
structure and function of the microbial colonies in the gut, which
has a strong effect on the immune response by either not generat-
ing tolerance or by causing inﬂammation leading to development
of autoimmune diseases. One mechanism used to explain the ben-
eﬁcial effects of commensals is their ability to hinder pathogen
adhesion; however, it does not necessarily address the potential
effects of commensal bacteria on the systemic immune system.
The ability of commensals to alter or modulate systemic immune
responses may be more germane for modifying systemic autoim-
mune responses and could provide an experimental framework
to explain how the increase in environmental hygiene could result
in an increase of autoimmune diseases. It is also clear that bacteria,
be they probiotic or commensals, are quite variable in their effects
and their general characterization as beneﬁcial or pathogenic
organisms do not do justice to the diversity of effects that the
different bacteria can induce or prevent.
We have coevolved with our gut commensals. There is consid-
erable evidence now that suggests that the intestinal microﬂora
or its speciﬁc components are important for the normal develop-
ment of the immune system and health of the host and altered
microbiota may be associated with disease conditions [13,16,
21,49,50].6. Microbiome and RA
Recent studies have suggested that bacterial products can lead
to production of pro-inﬂammatory molecules compromising the
intestinal barrier integrity. This can lead to leaky gut syndrome
which may explain the presence of gut bacteria in systemic
immune system. Altered gut microbial population can affect the
overall immune system in the gut with consequent changes in sys-
temic immune system.
The gut harbors around 1013 microbes with a vast majority
being anaerobic and difﬁcult to culture. An initial study analyzed
fatty acids produced by gastrointestinal bacteria to show that RA
patients with erosive disease differed from other subjects [51]. This
study was followed by analyzing the fecal microbiome of RA
patients that was done by 16S RNA sequencing of microbes in
the stool by reverse transcription polymerase chain reaction
(rtPCR). Patients with RA showed fewer Biﬁdobacterium, bacteria
of the Bacteroides–Porphyromonas–Prevotella group and the Eubac-
terium rectale–Clostridium coccoides group than the fecal microbi-
ota of patients with non-inﬂammatory ﬁbromyalgia [37],
suggesting dysbiosis as these are the common genera in humans
[52–54]. However, the information was very limited due to techni-
cal limitations.
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sible to sequence 16sRNA of the fecal microbiome of humans.
While the fecal microbiome may not reﬂect all of the microbiota
of the small intestine, it provides a window into the overall gastro-
intestinal microbiome. Using this approach, Scher and coworkers
[55] analyzed stool samples from new onset RA (NORA) patients
and controls. They identiﬁed an abundance of Prevotella copri with
loss of Bacteroides in NORA patients. Interestingly the relative
abundance of P. copri inversely correlated with the presence of
HLA alleles that share sequences of 3rd hypevariable region
(3HVR) called ‘‘shared epitope’’ suggesting a change in the gut mic-
robiota before onset of clinical phenotype. It is known that the
inﬂammatory response in RA begins much before the actual onset
of disease. These studies along with humanized mice suggest that
MHC genes play a critical role in the colonization of gastrointesti-
nal microbial ﬂora thus indirectly determining the pro-inﬂamma-
tory conditions in the gut.
In RA patients, smoking has been associated with seropositivity
and presence of DR4 [31]. Recent studies have suggested that
lungs, considered sterile before, harbor microbiota that changes
with conditions like chronic obstructive pulmonary disease [56].
It is possible that mucosal surfaces like lung and gut share
microbes as both organs are exposed to environmental factors. In
a genetically predisposed individual, the pathogenic microbes gen-
erate a pro-inﬂammatory milieu in both organs and the actual site
of initiation of RA might not be the joint.
However, it is impossible to determine causality versus effect in
humans due to variability in genetic complexity, diet, environmen-
tal factors and geographical locations. In addition, the likelihood
that RA patients are taking drugs that can modulate their gut mic-
robiota before being seen in a clinic, is high.
7. Gut microbiome in animal models for arthritis
Animal models provide a means to study the pathogen/antigen
involved in initiation of disease and its effect on the phenotype. As
early as 1977, animal models of arthritis using mycobacteria and
streptococcal cell wall components were described [57]. Animals
raised in germ-free colonies developed severe disease. In contrast,
HLA B27 transgenic rats and mice that develop spontaneous arthri-
tis modeling human spondyloarthropathies were protected from
spontaneous disease in germ-free and speciﬁc pathogen-free con-
ditions, respectively, suggesting a requirement of environmental
factors [58,59]. Similarly studies done with spontaneous mouse
models of RA, IL-1 receptor antagonist knockout and K/BXN mouse
models, have shown a requirement of gut microbiota for arthritis
development as mice raised in germ-free colony did not develop
arthritis [18,60]. Colonization of germ free mice with a single spe-
cies could trigger arthritis. The mechanism by which gut microbes
trigger extra-intestinal systemic disease was analyzed in the
K/BXN mouse model of spontaneous arthritis. Introduction of seg-
mented ﬁlamentous bacteria in germ-free K/BxN mice activates
TH17, a cytokine associated with RA [61], producing lamina
propria cells that migrate out of the gut and produce IL-17, helping
differentiation of B cells into antibody producing cells. How gut
microbiota exerts its effect locally in joints is remains largely
unknown.
Using transgenic mice expressing RA-associated DRB1*0401 and
resistant DRB1*0402 genes, we have developed a collagen-induced
arthritis (CIA) model that shares similarities with human disease in
sex-bias, autoantibody proﬁle and phenotype [62–64]. We
sequenced fecal ﬂora of ⁄0401 and ⁄0402 mice to identify composi-
tional differences in the intestinal microbiota between the 2
strains. Our data showed a signiﬁcant shift in the ratio of Bacteroi-
detes/Firmicutes with ⁄0401mice showing even abundance of bothphyla while in ⁄0402 mice Bacteroidetes occurred with twice the
abundance of Firmicutes. This suggested that (1) HLA genes may
have a role in gut microbial colonization and (2) a dysbiosis may
be present in genetically susceptible subjects indicating a crucial
role of gut ﬂora in the autoimmune process [23]. This was sup-
ported by the observations in this study since ⁄0401 mice did not
show dynamic changes in fecal microbiome with age although
⁄0402 mice showed a sex- and age-dependent microbiome. More-
over, gut permeability was much higher in ⁄0401 mice compared
to ⁄0402 mice further providing a mechanism by which the prod-
ucts of gut commensals may be migrating in extra-intestinal
organs. Arthritis-susceptible mice had an abundance of bacteria
with similarities to Clostridiales gp. while resistant mice had an
abundance of Biﬁdobacteria. The presence of biﬁdobacteriawas neg-
atively correlated to TH17 expression in the gut suggesting that
commensals in this group may have a dominant role in protection.
Bacterial rRNA from naturally occurring commensals like Clostrid-
ium have been isolated from synovial tissue of RA but not non-
RA patients [36]. These studies suggest that the intestine may be
a critical organ in triggering disease through altered immune
homeostasis and a leaky gut with proinﬂammatory conditions
may be an event that begins before the actual onset of clinical
phenotype.
This suggests that the gut microbiomemay dictate a pro or anti-
inﬂammatory environment that can have a substantial impact on
adaptive immune response away from gut. We propose that the
gut microbiome, sex and genetic factors may be able to predict sus-
ceptibility to develop autoimmunity like arthritis. Treatment of
arthritis-susceptible mice with a potential anti-inﬂammatory com-
mensal might help in stopping progression of disease and reducing
severity by changing gut permeability and the immune
environment.
The only probiotic tried as a treatment for RA is the Lactobacil-
lus. Its therapeutic application did not signiﬁcantly improve the
American College of Rheumatology Scores in one study, but did
show beneﬁt in another [65,66]. In mouse models of arthritis
L. casei potentiates antigen-speciﬁc oral tolerance and suppresses
TH1-type immune responses, key feature of RA [67–69]. A normal
intestinal microbiota can positively inﬂuence immune responses
and protect against the development of inﬂammatory diseases in
various models [70–72]. Molecules produced by intestinal bacteria
like B. fragilis can ameliorate inﬂammatory disease [71,73,74].
Despite these tantalizing reports, there is a paucity of data on the
composition of gut microbial population and its use as therapeutic
agents in inﬂammatory autoimmune diseases, particularly RA.
Current treatment of RA involves non-steroidal anti-inﬂamma-
tory drugs, known to increase gut permeability, as well as immu-
nosuppressive and biologic drugs. Although biologics like TNFa
inhibitors and CD20 depletion have been used successfully in RA
patients, not all patients respond to these therapies, and those
who do respond may develop adverse effects. Pharmacologic treat-
ments for arthritis target the inﬂammatory process by suppressing
the host reaction whereas commensals may regulate rather than
suppress the host response. If this proves to be successful, it would
open the possibility of inducing immune tolerance in other auto-
immune diseases with unknown etiology.
8. Conclusions
Recent technology has made it possible to culture the gut
microﬂora and understand their involvement in homeostasis of
immune system in the gut and in various diseases. From the pub-
lished observations, one can speculate that autoimmunity is the
result of many factors including genetic factors and environmental
factors like smoking, infections and diet that can inﬂuence the gut
Fig. 2. In genetically predisposed individuals, environmental factors like diet,
infections and smoking can cause dysbiosis in the gut microbiota resulting in
expansion of contraction of certain species of a genus. This dysbiosis may be related
to production of some metabolites as well as NFkB activation and TH17 cytokine
production, compromising the integrity of the gut epithelial layer and causing a
leaky gut and disease conditions. On the other hand a healthy individual will
maintain homeostasis in the gut so that the local and systemic immune systems
stay healthy. RA-Rheumatoid arthritis.
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maintains integrity of the gut and helps in various functions. On
the other hand, in genetically predisposed individuals, environ-
mental factors can inﬂuence dysbiosis of the gut microbiome, caus-
ing a change in the local and adaptive immune system in the gut
that compromises its integrity resulting in various disease condi-
tions. We propose that the characterization of the composition of
the intestinal microﬂora of RA patients and their healthy family
members could potentially deﬁne speciﬁc microbial species or eco-
logical properties, such as biodiversity, that may be responsible for
dysbiosis in patients. This will help in improving predictive and
diagnostic protocols for individuals at high risk of developing RA
and future treatment strategies. There is still a lot that needs to
be answered. Observations in mouse models and RA patients sug-
gest that the gut may be an important contributor to onset or
severity of disease. The next step will be to ﬁnd a way to modulate
disease by generating symbiosis in the gut microbial composition
by using diet, prebiotics or probiotics.
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